Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4542655
Max Phase: Preclinical
Molecular Formula: C36H51N5O6S
Molecular Weight: 681.90
Molecule Type: Unknown
Associated Items:
ID: ALA4542655
Max Phase: Preclinical
Molecular Formula: C36H51N5O6S
Molecular Weight: 681.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCC(CO)CC3)c3cc[nH]c3n2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C36H51N5O6S/c1-6-34(4)17-26(35(5)21(2)7-12-36(22(3)30(34)46)13-8-25(43)29(35)36)47-28(45)20-48-33-39-31-24(9-14-37-31)32(40-33)38-27(44)18-41-15-10-23(19-42)11-16-41/h6,9,14,21-23,26,29-30,42,46H,1,7-8,10-13,15-20H2,2-5H3,(H2,37,38,39,40,44)/t21-,22+,26-,29+,30+,34-,35+,36+/m1/s1
Standard InChI Key: PKZSVZOOTSNEGL-UFZKLDAOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 681.90 | Molecular Weight (Monoisotopic): 681.3560 | AlogP: 4.60 | #Rotatable Bonds: 9 |
Polar Surface Area: 157.74 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.47 | CX Basic pKa: 6.88 | CX LogP: 4.13 | CX LogD: 4.02 |
Aromatic Rings: 2 | Heavy Atoms: 48 | QED Weighted: 0.13 | Np Likeness Score: 0.44 |
1. Deng Y, Wang XZ, Huang SH, Li CH.. (2019) Antibacterial activity evaluation of synthetic novel pleuromutilin derivatives in vitro and in experimental infection mice., 162 [PMID:30445267] [10.1016/j.ejmech.2018.11.006] |
Source(1):